Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead, Part I: The atrial lead

M. Glikson, L. K. Von Feldt, Vera Jean Suman, D. L. Hayes

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Since 1989, 168 Telectronics model 330-801 active fixation, polyurethane insulated atrial leads (Accufix) have been implanted at the Mayo Clinic. There were four (2.4%) acute lead related complications, (i.e., perforation, microdislodgment, and pericarditis). Over a median follow-up time of 7.6 months (up to 2.7 years), there were 14 (8.3%) chronic complications, including 1 instance (0.6%) of definite lead failure. Most of these complications were early (within the first month) and transient. Four patients (2.4%) required reoperation for chronic complications. During follow-up, 23% of the examined patients had high pacing thresholds, most at about 3 months after implantation, necessitating high-output programming. The exact mechanism and natural history of this phenomenon should be further investigated.

Original languageEnglish (US)
Pages (from-to)1399-1404
Number of pages6
JournalPACE - Pacing and Clinical Electrophysiology
Volume17
Issue number8
DOIs
StatePublished - 1994

Fingerprint

Polyurethanes
Pericarditis
Natural History
Reoperation
Lead

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead, Part I : The atrial lead. / Glikson, M.; Von Feldt, L. K.; Suman, Vera Jean; Hayes, D. L.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 17, No. 8, 1994, p. 1399-1404.

Research output: Contribution to journalArticle

@article{23e53b7f46b0404bad9e299b081de6e1,
title = "Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead, Part I: The atrial lead",
abstract = "Since 1989, 168 Telectronics model 330-801 active fixation, polyurethane insulated atrial leads (Accufix) have been implanted at the Mayo Clinic. There were four (2.4{\%}) acute lead related complications, (i.e., perforation, microdislodgment, and pericarditis). Over a median follow-up time of 7.6 months (up to 2.7 years), there were 14 (8.3{\%}) chronic complications, including 1 instance (0.6{\%}) of definite lead failure. Most of these complications were early (within the first month) and transient. Four patients (2.4{\%}) required reoperation for chronic complications. During follow-up, 23{\%} of the examined patients had high pacing thresholds, most at about 3 months after implantation, necessitating high-output programming. The exact mechanism and natural history of this phenomenon should be further investigated.",
author = "M. Glikson and {Von Feldt}, {L. K.} and Suman, {Vera Jean} and Hayes, {D. L.}",
year = "1994",
doi = "10.1111/j.1540-8159.1994.tb02459.x",
language = "English (US)",
volume = "17",
pages = "1399--1404",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead, Part I

T2 - The atrial lead

AU - Glikson, M.

AU - Von Feldt, L. K.

AU - Suman, Vera Jean

AU - Hayes, D. L.

PY - 1994

Y1 - 1994

N2 - Since 1989, 168 Telectronics model 330-801 active fixation, polyurethane insulated atrial leads (Accufix) have been implanted at the Mayo Clinic. There were four (2.4%) acute lead related complications, (i.e., perforation, microdislodgment, and pericarditis). Over a median follow-up time of 7.6 months (up to 2.7 years), there were 14 (8.3%) chronic complications, including 1 instance (0.6%) of definite lead failure. Most of these complications were early (within the first month) and transient. Four patients (2.4%) required reoperation for chronic complications. During follow-up, 23% of the examined patients had high pacing thresholds, most at about 3 months after implantation, necessitating high-output programming. The exact mechanism and natural history of this phenomenon should be further investigated.

AB - Since 1989, 168 Telectronics model 330-801 active fixation, polyurethane insulated atrial leads (Accufix) have been implanted at the Mayo Clinic. There were four (2.4%) acute lead related complications, (i.e., perforation, microdislodgment, and pericarditis). Over a median follow-up time of 7.6 months (up to 2.7 years), there were 14 (8.3%) chronic complications, including 1 instance (0.6%) of definite lead failure. Most of these complications were early (within the first month) and transient. Four patients (2.4%) required reoperation for chronic complications. During follow-up, 23% of the examined patients had high pacing thresholds, most at about 3 months after implantation, necessitating high-output programming. The exact mechanism and natural history of this phenomenon should be further investigated.

UR - http://www.scopus.com/inward/record.url?scp=0028142539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028142539&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8159.1994.tb02459.x

DO - 10.1111/j.1540-8159.1994.tb02459.x

M3 - Article

C2 - 7971401

AN - SCOPUS:0028142539

VL - 17

SP - 1399

EP - 1404

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 8

ER -